GCEMS Protocol:

 

• Pediatric Reactive Airway Disease

 

INDICATIONS:

 

• Croup (Laryngotracheobronchitis)

 

 

DOSAGE:

ADULT:

 

• Not indicated for adult patients

 

PEDIATRIC:

 

• 0.5 ml (diluted to 3.0 ml with NS) nebulized; may not repeat
• Physician in the receiving ED should be notified that treatment has been administered

 

CONTRAINDICATIONS:

 

• Should not be used in the management of epiglottitis

 

SIDE EFFECTS:

 

• Can result in tachycardia and possible arrhythmias